The Hair in the Shower Drain

A familiar dread, back again

For a lot of mothers, the sight of hair collecting in the shower drain is not new. It is the same quiet dread that arrived a few months after giving birth. What surprises women on a GLP-1 is that it can return — sometimes a few months into meaningful weight loss — and that nobody warned them. It is one of the most searched side effects of this medication class, and it is also one of the most misunderstood. So let us report it plainly: for most women, this is not the drug poisoning your follicles. It is a well-described reaction to rapid change called telogen effluvium.

What telogen effluvium actually is

Hair grows in cycles. At any moment, most follicles are in a growth phase and a minority are resting, destined to shed. A significant physiological stress — childbirth, surgery, a high fever, or rapid weight loss — can push an unusually large share of follicles into the resting phase at once. Two or three months later, they let go together, and the shedding looks alarming precisely because it is synchronized. The mechanism is the same one behind postpartum hair loss, which is why it can feel so eerily familiar.

The weight-loss link is documented. In a retrospective study of patients with telogen effluvium tied to weight loss, the average loss was about 15% of body weight, and the great majority of patients — 110 of 140 — were women¹. That last detail matters for this magazine's readers: this is disproportionately a woman's experience.

It is not the medicine reaching into your scalp. It is your body reacting to how fast it changed — and that reaction has an expiration date.

Is it the drug, or the weight loss?

This is the question every woman wants answered, and the honest reply is: mostly the second, driven by the first. Dermatology reviews of hair loss in patients taking GLP-1 receptor agonists conclude that the shedding is best understood as telogen effluvium provoked by the rapid weight loss and the metabolic shift, rather than a direct toxic effect of the molecule on the follicle². A systematic review of GLP-1 therapies and hair loss reaches a similar read of the current evidence, while noting that rapid or large reductions in intake can also leave some patients short on the protein and micronutrients hair needs³. In plain terms: the faster and larger the loss, the more likely the shed — which is one more argument for the slow, measured titration we favor.

What actually helps

The most important intervention is also the least satisfying: time. Telogen effluvium is self-limited. Because the shed follicles are resting, not dead, they typically re-enter the growth phase, and most women see regrowth over the months after weight and intake stabilize. Beyond patience, the levers that have any grounding are boring and worth doing anyway — hitting your protein target, not crash-dieting on top of the medication, and asking a clinician to check for the usual culprits (iron, thyroid, vitamin D) that can worsen shedding independent of the drug. If shedding is severe, patchy, or still worsening well past the expected window, that is a reason to see a dermatologist rather than a supplement aisle.

None of this is a reason to abandon a medication that may be doing real good — but it is a reason to eat like someone who is trying to keep her hair, and to titrate at a pace her body can follow. If you are just starting out, build the protein habit early; if you are deep in it and rattled, know the timeline and read our reporting on the “new body” and its adjustments. This feature is educational only and is not medical advice.